Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Aristoforin

SIRT inhibitor
 
ALX-350-129-M001 1 mg 217.00 USD
Do you need bulk/larger quantities?
 
Stable and water-soluble derivative of hyperforin (Prod. No. ALX-350-097) inducing apoptosis. Antitumor agent. Inhibits sirtuins.

Product Specification

Formula:C37H54O6
 
MW:594.8
 
CAS:849215-53-8
 
Purity:≥95%
 
Identity:Identity determined by MS, 1H- and 13C-NMR.
 
Appearance:White to yellow oil.
 
Solubility:Soluble in DMSO or 100mM sodium hydrogen carbonate/2% DMSO.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Handling:Protect from light.
 
ALX-350-129 structure
Please mouse over
ALX-350-129 structure

Product Literature References

Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells: M. Šemeláková, et al.; Biomed. Pharmacother. 81, 38 (2016), Application(s): Cell culture, Abstract;
DNA-protective activities of hyperforin and aristoforin: A. Ševčovičová, et al.; Toxicol. In Vitro 29, 631 (2015), Application(s): Assay, Abstract;
Phloroglucinol Derivatives Guttiferone G, Aristoforin, and Hyperforin: Inhibitors of Human Sirtuins SIRT1 and SIRT2: C. Gey, et al.; Angew. Chem. Int. Ed. Engl. 46, 5219 (2007), Abstract;
Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent: M. Gartner, et al.; Chembiochem. 6, 171 (2005), Abstract;

Related Products

Hyperforin . dicyclohexylammonium salt (high purity) 

238074-03-8 (DCHA salt); 11079-53-1 (non-salt form), Isolated from St. John's wort (Hypericum perforatum)., ≥97% (HPLC) | Print as PDF
 
ALX-350-097-C500 500 µg 145.00 USD
 
ALX-350-097-M001 1 mg 253.00 USD
Do you need bulk/larger quantities?
 

Related Literature

Brochures
Stem Cells
Stem Cells
Download as PDF

Brochures
Epigenetics
Epigenetics
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,